Skip to content
No results
  • News
  • Press Releases
  • Business
  • Research
  • Regulatory
  • Events and Conferences

Preventive Medicine 2023

We use cookies to ensure that we give you the best experience on our website.
  • About Us
  • Contact Us
the-pharma-data-logo-color

Preventive Medicine 2023

  • News
  • Press Releases
  • Business
  • Research
  • Regulatory
  • Events and Conferences
the-pharma-data-logo-color
  • Research

Merck Provides Update from Open-Label Arm of Phase 2 KeyVibe-002 Trial Evaluating MK-7684A, a Coformulation of Vibostolimab and Pembrolizumab, in Previously Treated Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC)

  • ByThe Pharma Data
  • OnMarch 18, 2023

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today provided an update on the open-label arm of the non-registrational Phase 2 KeyVibe-002 trial. KeyVibe-002 is…

Read More
  • News

Statement on the update of WHO’s working definitions and tracking system for SARS-CoV-2 variants of concern and variants of interest

  • ByThe Pharma Data
  • OnMarch 18, 2023

WHO has updated its tracking system and working definitions for variants of SARS-CoV-2, the virus that causes COVID-19, to better correspond to the current global variant landscape, to independently evaluate…

Read More
  • News

Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature

  • ByThe Pharma Data
  • OnMarch 16, 2023

The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans Findings support further clinical development for prevention and treatment of dengue, which impacts millions of people…

Read More
  • News

Bristol Myers Squibb Announces Progress Toward Long-Term Inclusion & Diversity Goals and Health Equity Commitments

  • ByThe Pharma Data
  • OnMarch 16, 2023

Commitments demonstrate leadership in advancing health equity and workforce representation to better serve patients and communities – $10 million in 2023 grant funding to 17 U.S. organizations focused on addressing social determinants…

Read More
  • Business

Pfizer and BioNTech Receive U.S. Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Booster in Children Under 5 Years

  • ByThe Pharma Data
  • OnMarch 16, 2023

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) to provide a single booster dose…

Read More
  • News

Five cities recognized for public health achievements at Partnership for Healthy Cities Summit

  • ByThe Pharma Data
  • OnMarch 16, 2023

artnership for Healthy Cities award recipients include Montevideo, Uruguay for food policy; Mexico City, Mexico for road safety; Vancouver, Canada for surveillance; Athens, Greece for overdose prevention, and Bengaluru, India…

Read More
  • Business

Pfizer invests $43 billion to battle cancer

  • ByThe Pharma Data
  • OnMarch 14, 2023

Pfizer Inc. and Seagen Inc. today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Seagen, a global biotechnology company that discovers, develops and…

Read More
  • News

WHO renews alert on safeguards for health worker recruitment

  • ByThe Pharma Data
  • OnMarch 14, 2023

The World Health Organization (WHO) released today an updated WHO health workforce support and safeguards list 2023, identifying 55 countries as vulnerable for availability of health workers required to achieve the…

Read More
  • News

Biogen Appoints Chuck Triano as Head of Investor Relations

  • ByThe Pharma Data
  • OnMarch 14, 2023

 Biogen Inc. today announced the appointment of Chuck Triano as Senior Vice President, Head of Investor Relations effective 10 April 2023. Mr. Triano will report to Michael McDonnell, Executive Vice…

Read More
  • Business

Bayer collaborates with Microsoft to unveil new cloud-based enterprise solutions, advancing innovation and transparency in the agri-food industry

  • ByThe Pharma Data
  • OnMarch 14, 2023

Ready-to-use AgPowered Services from Bayer running on the new Microsoft Azure Data Manager for Agriculture / Readymade capabilities and robust digital infrastructure allow innovators to focus on differentiated value /…

Read More
AI tailors artificial DNA for future drug development
  • News

Results from Astellas’ Pivotal Phase 3 SKYLIGHT 1™ Study of Fezolinetant for Vasomotor Symptoms Due to Menopause Published in The Lancet

  • ByThe Pharma Data
  • OnMarch 14, 2023

Treatment with fezolinetant resulted in statistically significant reductions in the frequency and severity of VMS and improvements in quality of life Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji…

Read More
  • Business

Astellas Announces Phase 3 China ARCHES Study of XTANDI® Meets Primary Endpoint

  • ByThe Pharma Data
  • OnMarch 14, 2023

XTANDI® (enzalutamide) plus androgen deprivation therapy (ADT) significantly delays time to PSA progression compared to placebo plus ADT Study enrolled 180 men with metastatic hormone-sensitive prostate cancer in mainland China Astellas…

Read More
Prev
1 2 3 4 5 6 … 106
Next
Pediatric Academic Societies Meetimg (PAS) 2023
Global Pharma & Drug Delivery Summit 2023
ACPM 2023
ECBIP 2023
The 15th Paris Hepatology Conference 2023
ASGBI annual conference 2023
37th NASPAG Annual Clinical & Research Meeting 2023
18th Congress MESOT 2023
AMGA’s 2023 Annual Conference (AC23) 

About

The Pharma Data Is An Information-Centric Website Focused Mainly On The Pharmaceutical Industry Online It Is A B2B Platform Mainly Focused On The Latest Pharmaceutical News, Press Release, Industry-Related Updates, Events, And Conferences. With The Pharma Data, You Can Get All Information That Happens In The Pharmaceutical Industry.

Advertise With Us: marketing@thepharmadata.com

Quick Links

  • News
  • Press Releases
  • Business
  • Research
  • Regulatory
  • Events and Conferences
  • About Us
  • Contact Us
  • Privacy Policy
  • Disclaimer
  • Terms and Conditions

Copyright © 2023 | The Pharma Data | Marnet Technologies Pvt Ltd. | Al Rights Reserved

Facebook Twitter LinkedIn